Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

TOKE vs. FQTEX: which is better?

Bottom line

TOKE vs FQTEX: the short answer

TOKE (Cambria Cannabis ETF) and FQTEX (Franklin Templeton SMACS: Series E) are both etfs.

FQTEX is cheaper at 0% vs 0.44% — a difference of $44 a year per $10,000 invested.

Over five years, FQTEX returned +9.8% a year vs −16.2% for TOKE.

Updated Nov 19, 2026

TOKE vs FQTEX side by side

TOKEFQTEX
TypeETFMutual fund
Fund familyCambriaFranklin Templeton
CategoryOtherOther
Expense ratio0.44%0%
Annual cost per $10k$44$0
10-yr cost on $10k (prospectus)$746$94
Max front loadNone—
12b-1 fee0%0%
1-yr return−7.4%+11.4%
5-yr return (annualized)−16.2%+9.8%
10-yr return (annualized)——
Best quarter+39.9%+15.2%
Worst quarter−32.6%−23.2%
Net assets (fund)—$626.0M
Number of holdings—114
Portfolio turnover33%103%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearTOKEFQTEXDifference
2024−7.4%+11.4%−18.8%
2023−9.9%+11.6%−21.5%
2022−44.3%−0.9%−43.4%
2021−12.8%+25.4%−38.2%
2020+2.0%+3.3%−1.3%

Source: Fund prospectus bar charts

Holdings overlap

TOKE and FQTEX share none of their top holdings.

TOKE top 10

    FQTEX top 10

    1. Ares Management Corp. — 4.35%
    2. Boeing Co. (The) — 3.63%
    3. NextEra Energy, Inc. — 3.16%
    4. Shell plc — 3.04%
    5. Albemarle Corp. — 2.49%
    6. Medtronic plc — 2.36%
    7. UnitedHealth Group, Inc. — 2.13%
    8. Philip Morris International, Inc. — 1.91%
    9. TotalEnergies SE — 1.81%
    10. McDonald's Corp. — 1.78%

    FAQ

    What is the difference between TOKE and FQTEX?
    TOKE (Cambria Cannabis ETF) and FQTEX (Franklin Templeton SMACS: Series E) are both etfs. FQTEX is cheaper at 0% vs 0.44% — a difference of $44 a year per $10,000 invested.
    Which is cheaper, TOKE or FQTEX?
    FQTEX has the lower expense ratio (0%).
    Should I own both TOKE and FQTEX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.